2026 AAPS PharmSci 360 Annual Meeting & Expo, USA

The 2026 AAPS PharmSci 360 Annual Meeting & Exposition in the USA (AAPS PharmSci 360) is one of the most influential and forward-thinking annual events in the global pharmaceutical sciences field. AAPS, the American Association of Pharmaceutical Scientists, has been dedicated to advancing pharmaceutical sciences since its inception. PharmSci 360, as its flagship event, aims to bring together leading scientists, researchers, industry experts, regulatory representatives, and corporate decision-makers from around the world to discuss the latest research findings, technological innovations, industry trends, and future challenges in the pharmaceutical sector. The exhibition is grand in scale, annually attracting thousands of professional visitors and hundreds of exhibitors, covering the entire industry chain from drug discovery, development, and manufacturing to regulation and commercialization. Its influence is not only reflected in the depth and breadth of academic exchange but also in its role as an efficient platform for collaboration and business expansion for the industry. Exhibitors include large pharmaceutical companies, biotechnology companies, contract research organizations (CROs), contract manufacturing organizations (CMOs), instrument and equipment suppliers, raw material suppliers, software and service providers, etc. Through keynote speeches, symposia, poster presentations, technical exchange sessions, and the concurrently held professional exhibition, PharmSci 360 provides attendees with an excellent platform to comprehensively understand industry dynamics, learn cutting-edge knowledge, expand professional networks, and seek cooperation opportunities. The exhibition not only focuses on breakthroughs in basic scientific research but also highly values translational medicine and clinical applications, striving to transform the latest research findings into practical drug products for the benefit of human health. Its authority and global influence in pharmaceutical sciences make it an indispensable and important event in the industry.

The exhibit range of the 2026 AAPS PharmSci 360 Annual Meeting & Exposition in the USA is extremely broad, covering all aspects of pharmaceutical science and technology, aiming to comprehensively showcase the products, technologies, and services required from drug discovery to commercialization. Specific exhibit categories include, but are not limited to: 1. **Drug Discovery and Early Development**: Including high-throughput screening technologies, drug target identification and validation, lead compound optimization, computational chemistry and molecular modeling, medicinal chemistry synthesis, biological activity assays, in vitro pharmacodynamics and pharmacokinetics studies, toxicology assessment, biomarker development, etc. 2. **Drug Formulation and Delivery Systems**: Covers oral solid dosage forms, liquid formulations, injectables, inhaled formulations, transdermal formulations, sustained/controlled-release formulations, nanomedicines, biologics, gene therapy and cell therapy products, novel drug delivery technologies, excipients, and packaging materials. 3. **Biopharmaceuticals and Biotechnology**: Includes antibody drugs, recombinant proteins, vaccines, cell therapy, gene therapy, biosimilars, bioprocess development and optimization, bioreactors, cell culture media, purification technologies, bioanalysis, etc. 4. **Pharmaceutical Manufacturing and Quality Control**: Showcases pharmaceutical equipment (e.g., tablet presses, capsule fillers, lyophilizers, sterilization equipment, packaging equipment), cleanroom technology and equipment, quality control instruments (e.g., HPLC, GC, mass spectrometers, UV/Vis spectrophotometers, particle size analyzers), laboratory consumables, GMP compliance solutions, data integrity management, validation services, etc. 5. **Analytical Science and Testing Services**: Includes drug structural analysis, component identification, impurity analysis, stability testing, dissolution testing, bioanalysis, clinical trial sample analysis, CRO services, CMO services, contract research and manufacturing services, etc. 6. **Pharmaceutical IT and Automation**: Covers laboratory information management systems (LIMS), electronic laboratory notebooks (ELN), clinical data management systems (CDMS), drug discovery and development software, artificial intelligence and machine learning applications in drug development, automated production lines, Internet of Things (IoT) solutions, big data analytics, etc. 7. **Regulatory Affairs and Compliance**: Provides interpretation of the latest regulations from regulatory bodies such as FDA, EMA, registration and submission services, quality system consulting, clinical trial design and management, intellectual property protection, etc. 8. **Other Related Services and Products**: Such as professional publications, industry consulting, talent recruitment, education and training, biobanks, cold chain logistics, etc. These exhibits collectively form a comprehensive and in-depth display platform for the pharmaceutical sciences field, providing attendees with valuable opportunities to understand the latest technologies, seek collaborations, and drive innovation.

No fee information available. Please contact us for a quote.